vs

Side-by-side financial comparison of Clorox (CLX) and Lam Research (LRCX). Click either name above to swap in a different company.

Lam Research is the larger business by last-quarter revenue ($5.8B vs $1.7B, roughly 3.5× Clorox). Lam Research runs the higher net margin — 31.2% vs 11.4%, a 19.8% gap on every dollar of revenue. On growth, Lam Research posted the faster year-over-year revenue change (23.8% vs 0.1%). Over the past eight quarters, Lam Research's revenue compounded faster (22.8% CAGR vs -4.1%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Lam Research Corporation is an American supplier of wafer-fabrication equipment and related services to the semiconductor industry. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices and their wiring (interconnects). The company also builds equipment for back-end wafer-level packaging (WLP) and for related manufacturing markets such as for microelectromechanical systems (MEMS).

CLX vs LRCX — Head-to-Head

Bigger by revenue
LRCX
LRCX
3.5× larger
LRCX
$5.8B
$1.7B
CLX
Growing faster (revenue YoY)
LRCX
LRCX
+23.6% gap
LRCX
23.8%
0.1%
CLX
Higher net margin
LRCX
LRCX
19.8% more per $
LRCX
31.2%
11.4%
CLX
Faster 2-yr revenue CAGR
LRCX
LRCX
Annualised
LRCX
22.8%
-4.1%
CLX

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
CLX
CLX
LRCX
LRCX
Revenue
$1.7B
$5.8B
Net Profit
$191.0M
$1.8B
Gross Margin
43.2%
49.8%
Operating Margin
35.0%
Net Margin
11.4%
31.2%
Revenue YoY
0.1%
23.8%
Net Profit YoY
0.5%
37.2%
EPS (diluted)
$1.54
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
LRCX
LRCX
Q1 26
$1.7B
$5.8B
Q4 25
$1.7B
$5.3B
Q3 25
$5.3B
Q2 25
$2.0B
$5.2B
Q1 25
$1.7B
$4.7B
Q4 24
$1.7B
$4.4B
Q3 24
$1.8B
$4.2B
Q2 24
$1.9B
$3.9B
Net Profit
CLX
CLX
LRCX
LRCX
Q1 26
$191.0M
$1.8B
Q4 25
$157.0M
$1.6B
Q3 25
$1.6B
Q2 25
$332.0M
$1.7B
Q1 25
$186.0M
$1.3B
Q4 24
$193.0M
$1.2B
Q3 24
$99.0M
$1.1B
Q2 24
$216.0M
$1.0B
Gross Margin
CLX
CLX
LRCX
LRCX
Q1 26
43.2%
49.8%
Q4 25
43.2%
49.6%
Q3 25
50.4%
Q2 25
46.5%
50.1%
Q1 25
44.6%
49.0%
Q4 24
43.8%
47.4%
Q3 24
45.8%
48.0%
Q2 24
46.5%
47.5%
Operating Margin
CLX
CLX
LRCX
LRCX
Q1 26
35.0%
Q4 25
33.9%
Q3 25
34.4%
Q2 25
20.6%
33.7%
Q1 25
15.2%
33.1%
Q4 24
14.1%
30.5%
Q3 24
10.0%
30.3%
Q2 24
14.5%
29.1%
Net Margin
CLX
CLX
LRCX
LRCX
Q1 26
11.4%
31.2%
Q4 25
9.4%
29.8%
Q3 25
29.5%
Q2 25
16.7%
33.3%
Q1 25
11.2%
28.2%
Q4 24
11.4%
27.2%
Q3 24
5.6%
26.8%
Q2 24
11.4%
26.4%
EPS (diluted)
CLX
CLX
LRCX
LRCX
Q1 26
$1.54
$1.45
Q4 25
$1.29
$1.26
Q3 25
$1.24
Q2 25
$2.68
$1.34
Q1 25
$1.50
$1.03
Q4 24
$1.54
$0.92
Q3 24
$0.80
$0.86
Q2 24
$1.74
$7.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
LRCX
LRCX
Cash + ST InvestmentsLiquidity on hand
$1.2B
$4.8B
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$92.0M
Total Assets
$6.4B
$20.8B
Debt / EquityLower = less leverage
27.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
LRCX
LRCX
Q1 26
$1.2B
$4.8B
Q4 25
$227.0M
$6.2B
Q3 25
$6.7B
Q2 25
$167.0M
$6.4B
Q1 25
$226.0M
$5.5B
Q4 24
$290.0M
$5.7B
Q3 24
$278.0M
$6.1B
Q2 24
$202.0M
$5.8B
Total Debt
CLX
CLX
LRCX
LRCX
Q1 26
$2.5B
Q4 25
$3.7B
Q3 25
$3.7B
Q2 25
$2.5B
$3.7B
Q1 25
$3.7B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$2.5B
$4.5B
Stockholders' Equity
CLX
CLX
LRCX
LRCX
Q1 26
$92.0M
Q4 25
$-125.0M
$10.1B
Q3 25
$10.2B
Q2 25
$321.0M
$9.9B
Q1 25
$27.0M
$9.5B
Q4 24
$-41.0M
$8.8B
Q3 24
$60.0M
$8.5B
Q2 24
$328.0M
$8.5B
Total Assets
CLX
CLX
LRCX
LRCX
Q1 26
$6.4B
$20.8B
Q4 25
$5.6B
$21.4B
Q3 25
$21.9B
Q2 25
$5.6B
$21.3B
Q1 25
$5.5B
$20.0B
Q4 24
$5.6B
$19.8B
Q3 24
$5.5B
$19.5B
Q2 24
$5.8B
$18.7B
Debt / Equity
CLX
CLX
LRCX
LRCX
Q1 26
27.03×
Q4 25
0.37×
Q3 25
0.37×
Q2 25
7.74×
0.38×
Q1 25
0.39×
Q4 24
0.51×
Q3 24
0.53×
Q2 24
7.56×
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
LRCX
LRCX
Operating Cash FlowLast quarter
$1.1B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
7.2%
5.7%
Cash ConversionOCF / Net Profit
0.63×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
LRCX
LRCX
Q1 26
$1.1B
Q4 25
$1.5B
Q3 25
$1.8B
Q2 25
$294.0M
$2.6B
Q1 25
$286.0M
$1.3B
Q4 24
$180.0M
$741.9M
Q3 24
$221.0M
$1.6B
Q2 24
$340.0M
$862.4M
Free Cash Flow
CLX
CLX
LRCX
LRCX
Q1 26
Q4 25
$1.2B
Q3 25
$1.6B
Q2 25
$219.0M
$2.4B
Q1 25
$233.0M
$1.0B
Q4 24
$127.0M
$553.6M
Q3 24
$182.0M
$1.5B
Q2 24
$259.0M
$761.7M
FCF Margin
CLX
CLX
LRCX
LRCX
Q1 26
Q4 25
22.8%
Q3 25
29.9%
Q2 25
11.0%
46.1%
Q1 25
14.0%
21.6%
Q4 24
7.5%
12.7%
Q3 24
10.3%
35.0%
Q2 24
13.6%
19.7%
Capex Intensity
CLX
CLX
LRCX
LRCX
Q1 26
7.2%
5.7%
Q4 25
4.9%
Q3 25
3.5%
Q2 25
3.8%
3.3%
Q1 25
3.2%
6.1%
Q4 24
3.1%
4.3%
Q3 24
2.2%
2.7%
Q2 24
4.3%
2.6%
Cash Conversion
CLX
CLX
LRCX
LRCX
Q1 26
0.63×
Q4 25
0.93×
Q3 25
1.13×
Q2 25
0.89×
1.48×
Q1 25
1.54×
0.98×
Q4 24
0.93×
0.62×
Q3 24
2.23×
1.40×
Q2 24
1.57×
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons